DRTS

Alpha Tau Medical Ltd. is a healthcare company operating in the biotechnology industry, with a market capitalization of $445.08M and approximately 125 employees. The company's financial health indicates significant losses, with net income totaling -$39,967,000 and EBITDA standing at -$38,837,000 over the trailing twelve months. Profitability metrics, including gross margin, operating margin, and profit margin, are all at 0.0%. Return on Equity (ROE) and Return on Assets (ROA) are negative at -54.4% and -25.6%, respectively. The company's balance sheet shows a debt-to-equity ratio of 17.40, with cash totaling $72.21M and debt standing at $13.50M. Alpha Tau Medical Ltd.'s valuation metrics include a forward P/E ratio of -10.86 and an EV/EBITDA ratio of -9.09, indicating significant losses. The Price to Book ratio stands at 5.74. Beta is reported at 1.04, providing context for the company's volatility relative to the market.